« Previous
Next »
Contraception
Volume 80, Issue 1
, Pages
18-24
, July 2009
Efficacy and safety of a low-dose combined oral contraceptive containing drospirenone 3 mg and ethinylestradiol 20 mcg in a 24/4-day regimen
To access this article, please choose from the options below
☆ This study was supported by an unrestricted grant from Bayer Schering Pharma AG, Berlin, Germany.
PII: S0010-7824(09)00037-7
doi: 10.1016/j.contraception.2009.01.016
© 2009 Elsevier Inc. All rights reserved.
« Previous
Next »
Contraception
Volume 80, Issue 1
, Pages
18-24
, July 2009
